机构：[1]Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.[2]Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore 999002, Singapore.[3]Department of Rheumatology and Immunology, Xinxiang Central Hospital, Xinxiang 453000, China.[4]Department of Rheumatology and Immunology, The Southwest Hospital of Army Medical University, Chongqing 404100, China.[5]Department of Rheumatology and Immunology, Sun Yat-sen University Sixth Affiliated Hospital, Guangzhou 510275, China.中山大学附属第六医院[6]Department of Rheumatology and Immunology, The First People's Hospital of Yunnan Province, Kunming 650300, China.内科片风湿免疫科云南省第一人民医院[7]Department of Rheumatology and Immunology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China.华中科技大学同济医学院附属协和医院[8]Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China.[9]Department of Rheumatology and Immunology, Air Force Medical University, Xi'an 710000, China.[10]Department of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.[11]Department of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang 050000, China.[12]Department of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang 110000, China.[13]Department of Rheumatology and Immunology, Linyi People's Hospital, Linyi 273300, China.[14]Department of Rheumatology and Immunology, Shaoxing People's Hospital, Shaoxing 310009, China.[15]Department of Rheumatology and Immunology, Affiliated Hospital of Nantong University, Nantong 226001, China.[16]Department of Rheumatology and Immunology, Xinjiang Medical University Affiliated First Hospital, Urumqi 830001, China.[17]Department of Rheumatology and Immunology, First People's Hospital of Jingzhou, Jingzhou 434000, China.[18]Department of Rheumatology and Immunology, Dongguan Tungwah Hospital, Dongguan 523000, China.[19]Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
The coronavirus disease 2019 (COVID-19) pandemic has imposed enormous morbidity and mortality burdens. Patients with rheumatic diseases (RDs) are vulnerable to the COVID-19 infection, given their immunocompromised status. Ensuring acceptance of the COVID-19 vaccine is important and has attracted attention by health professionals. In this study, we designed an online cross-sectional survey that used an online questionnaire from 8 May 2021 to 4 October 2021. Attitudes toward the COVID-19 vaccination, personal information, current disease activity status, adverse events (AEs), and knowledge sources of vaccines were collected. Descriptive statistics, nonparametric tests, and ordinal logistic regression were used to analyze the data. A total of 1022 questionnaires were received, among which 70.2% (720/1022) of patients with RDs agreed to vaccination, while only 31.6% of patients were actually vaccinated. Male, employed, high-income patients and those with inactive disease showed a more positive attitude. Concerns of AEs and disease flare were the main factors affecting vaccination willingness. Only 29.6% (304/1022) of patients thought they had received enough information about the COVID-19 vaccine from their doctors. In conclusion, most patients with RDs in China intended to get vaccinated, although the vaccination rate in this particular population was low. Rheumatologists should take more responsibility in COVID-19 vaccination education of patients with RDs.
基金：
This research was funded by grants from Clinical Cohort Construction Program of Peking
University Third Hospital (No. BYSYDL2021005).
第一作者机构：[1]Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Yi Zixi,Yao Zhongqiang,Xu Dan,et al.Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases[J].Vaccines.2022,10(10):doi:10.3390/vaccines10101604.
APA：
Yi Zixi,Yao Zhongqiang,Xu Dan,Xu Chuanhui,Fang Wenqiang...&Mu Rong.(2022).Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases.Vaccines,10,(10)
MLA：
Yi Zixi,et al."Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases".Vaccines 10..10(2022)
